Moderna Inc. stock falls Wednesday, underperforms market

This article was originally published on this site

© Terrence Horan


Shares of Moderna Inc. MRNA shed 0.39% to $124.06 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.43% to 13,128.95 and the Dow Jones Industrial Average DJIA falling 0.03% to 31,060.47. The stock’s fall snapped a two-day winning streak. Moderna Inc. closed $54.44 short of its 52-week high ($178.50), which the company reached on December 1st.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV rose 2.43% to $112.45, Amgen Inc. AMGN rose 0.49% to $237.74, and AstraZeneca PLC ADR AZN rose 1.17% to $50.88. Trading volume (14.1 M) remained 12.1 million below its 50-day average volume of 26.3 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading